Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians.

Portincasa P, Di Ciaula A, Grattagliano I.

Korean J Fam Med. 2016 Jul;37(4):205-13. doi: 10.4082/kjfm.2016.37.4.205. Epub 2016 Jul 21. Review.

2.

The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Zhu Q, Sun X, Ji X, Zhu L, Xu J, Wang C, Zhang C, Xue F, Liu Y.

Sci Rep. 2016 Jul 22;6:29937. doi: 10.1038/srep29937.

3.

Gallbladder motility and the sex of the guinea pig.

Kline L, Karpinski E.

Physiol Rep. 2016 Jun;4(12). pii: e12843. doi: 10.14814/phy2.12843.

4.

Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies.

Tan W, Gao M, Liu N, Zhang G, Xu T, Cui W.

Nutrients. 2015 Sep 25;7(10):8321-34. doi: 10.3390/nu7105387. Review.

5.

The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.

de Bari O, Wang HH, Portincasa P, Liu M, Wang DQ.

Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2161-9. doi: 10.1016/j.bbadis.2015.07.020. Epub 2015 Jul 30.

PMID:
26232687
6.

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.

Mawet M, Maillard C, Klipping C, Zimmerman Y, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):463-75. doi: 10.3109/13625187.2015.1068934. Epub 2015 Jul 27.

7.

Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.

de Bari O, Wang TY, Liu M, Portincasa P, Wang DQ.

J Lipid Res. 2015 Sep;56(9):1691-700. doi: 10.1194/jlr.M059121. Epub 2015 Jul 7.

8.

A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.

Roehm E.

Obstet Gynecol Int. 2015;2015:713295. doi: 10.1155/2015/713295. Epub 2015 Jan 1.

9.

Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population.

Liu J, Lin H, Zhang C, Wang L, Wu S, Zhang D, Tang F, Xue F, Liu Y.

BMC Gastroenterol. 2014 Dec 13;14:213. doi: 10.1186/s12876-014-0213-y.

10.

Menopause care for obese and diabetic women.

Verhaeghe J.

Facts Views Vis Obgyn. 2009;1(2):142-52. Review.

11.

Osteoporosis increases subsequent risk of gallstone: a nationwide population-based cohort study in Taiwan.

Klahan S, Kuo CN, Chien SC, Lin YW, Lin CY, Lin CH, Chang WC, Lin CI, Hung KS, Chang WP.

BMC Gastroenterol. 2014 Nov 18;14:192. doi: 10.1186/s12876-014-0192-z.

12.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

13.

Abdominal regional fat distribution on MRI correlates with cholecystolithiasis.

Zhang Y, Chen TW, Zhang XM, Wang YX, Chi XX, Li XH, Gao XF, Ji YF.

PLoS One. 2014 Oct 13;9(10):e109776. doi: 10.1371/journal.pone.0109776. eCollection 2014.

14.

Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.

de Bari O, Wang HH, Portincasa P, Paik CN, Liu M, Wang DQ.

Eur J Clin Invest. 2014 Dec;44(12):1159-68. doi: 10.1111/eci.12350. Epub 2014 Nov 4.

15.

Gynaecological aspects of the treatment and follow-up of transsexual men and women.

Weyers S, De Sutter P, Hoebeke S, Monstrey G, 'T Sjoen G, Verstraelen H, Gerris J.

Facts Views Vis Obgyn. 2010;2(1):35-54. Review.

16.

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Carbonnel F, Boutron-Ruault MC.

CMAJ. 2013 Apr 16;185(7):555-61. doi: 10.1503/cmaj.121490. Epub 2013 Mar 18.

17.

Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.

Bretler DM, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Jensen TB, Raunsø J, Torp-Pedersen C, Gislason GH.

PLoS One. 2012;7(12):e51580. doi: 10.1371/journal.pone.0051580. Epub 2012 Dec 17.

18.

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.

Maximov PY, Lee TM, Jordan VC.

Curr Clin Pharmacol. 2013 May;8(2):135-55. Review.

19.

Epidemiology of gallbladder disease: cholelithiasis and cancer.

Stinton LM, Shaffer EA.

Gut Liver. 2012 Apr;6(2):172-87. doi: 10.5009/gnl.2012.6.2.172. Epub 2012 Apr 17.

20.

Concept of the pathogenesis and treatment of cholelithiasis.

Reshetnyak VI.

World J Hepatol. 2012 Feb 27;4(2):18-34. doi: 10.4254/wjh.v4.i2.18.

Items per page

Supplemental Content

Write to the Help Desk